HealthSport Inc. Rated ‘Speculative Buy,’ Target Price $4.00 by Beacon Equity Research
HealthSport Inc. (OTCBB: HSPO) has been rated “Speculative Buy” with a target price of $4.00 by Beacon Equity Research.
The full report is available at http://www.BeaconEquityResearch.com.
In the report, the analyst writes, “HealthSport, Inc. develops, manufactures and markets nutritional supplements in a unique edible film strip delivery system. The Company currently markets its electrolyte strips under the Enlyten SportStrips™ in lemon-lime, orange and sour orange flavors. The strips are used as nutritional supplements to replenish energy during periods of exertion. HealthSport is currently focused on the sports activity replenishment segment. In addition, the Company is developing other edible film strip products for hangover recovery, mineral replacement and a variety of other applications.”
In April 2005, HealthSport contracted with InnoZen, Inc. to jointly develop a film strip product containing electrolytes. In May 2007, the Company acquired InnoZen. This acquisition will facilitate HealthSport’s ability to formulate and develop new edible film products and delivery systems for nutritional supplements and over-the-counter drug applications.
Other companies in the nutritional supplement market include Kraft Foods (NYSE:KFT), Herbalife (NASDAQ: HLF) Nutracea (OTCBB: NTRZ) and NBTY, Inc (NYSE: NTY).
Beacon Equity Research Disclosure
The analysts contributing to this report do not hold any shares of HealthSport Inc. (HSPO). Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research (“Beacon”) certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report. Beacon has directly been compensated a total of ten thousand dollars from a non-controlling third party (Onyx Consulting) for enrollment in its research program. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.
SOURCE: HealthSport Inc.
Beacon Equity Research
